These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 36982717)
41. Clinical utility of reticulocyte hemoglobin equivalent in patients with heart failure. Tahara S; Naito Y; Okuno K; Yasumura S; Horimatsu T; Ohno J; Sunayama I; Matsumoto Y; Manabe E; Masai K; Azuma K; Nishimura K; Min KD; Goda A; Asakura M; Ishihara M Sci Rep; 2022 Aug; 12(1):13978. PubMed ID: 35978001 [TBL] [Abstract][Full Text] [Related]
42. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence. Gonzalez-Costello J; Cainzos-Achirica M; Lupón J; Farré N; Moliner-Borja P; Enjuanes C; de Antonio M; Fuentes L; Díez-López C; Bayés-Genis A; Manito N; Pujol R; Comin-Colet J Eur J Intern Med; 2020 Oct; 80():91-98. PubMed ID: 32439287 [TBL] [Abstract][Full Text] [Related]
43. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease. Eisenga MF; Nolte IM; van der Meer P; Bakker SJL; Gaillard CAJM BMC Nephrol; 2018 Sep; 19(1):225. PubMed ID: 30208847 [TBL] [Abstract][Full Text] [Related]
44. Iron Deficiency in Heart Failure with Reduced Ejection Fraction: Pathophysiology, Diagnosis and Treatment. Pereira GAR; Beck-da-Silva L Arq Bras Cardiol; 2022 Mar; 118(3):646-654. PubMed ID: 35319614 [TBL] [Abstract][Full Text] [Related]
45. Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia. Guedes M; Muenz D; Zee J; Lopes MB; Waechter S; Stengel B; Massy ZA; Speyer E; Ayav C; Finkelstein F; Sesso R; Pisoni RL; Robinson BM; Pecoits-Filho R Nephrol Dial Transplant; 2021 Aug; 36(9):1694-1703. PubMed ID: 33624825 [TBL] [Abstract][Full Text] [Related]
46. Effect of Ferric Carboxymaltose Supplementation in Patients with Heart Failure with Preserved Ejection Fraction: Role of Attenuated Oxidative Stress and Improved Endothelial Function. Mollace A; Macrì R; Mollace R; Tavernese A; Gliozzi M; Musolino V; Carresi C; Maiuolo J; Nicita M; Caminiti R; Paone S; Barillà F; Volterrani M; Mollace V Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501086 [TBL] [Abstract][Full Text] [Related]
47. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis. Anker SD; Khan MS; Butler J; von Haehling S; Jankowska EA; Ponikowski P; Friede T Eur J Heart Fail; 2023 Jul; 25(7):1080-1090. PubMed ID: 37062867 [TBL] [Abstract][Full Text] [Related]
48. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial. Cleland JGF; Kalra PA; Pellicori P; Graham FJ; Foley PWX; Squire IB; Cowburn PJ; Seed A; Clark AL; Szwejkowski B; Banerjee P; Cooke J; Francis M; Clifford P; Wong A; Petrie C; McMurray JJV; Thomson EA; Wetherall K; Robertson M; Ford I; Kalra PR; Eur Heart J; 2024 Apr; 45(16):1410-1426. PubMed ID: 38446126 [TBL] [Abstract][Full Text] [Related]
49. Iron Status and Homeostasis Across 2 Competitive Seasons in NCAA Division I Collegiate Cross-Country Runners Residing at Low Altitude. Goodrich JA; Frisco DJ; Kim S; VanBaak K; Holliday M; Rueda M; Poddar S; Byrnes WC Int J Sports Physiol Perform; 2022 Dec; 17(12):1716-1724. PubMed ID: 36343619 [TBL] [Abstract][Full Text] [Related]
50. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial. Palau P; López L; Domínguez E; de La Espriella R; Campuzano R; Castro A; Miñana G; Fernández-Cisnal A; Sanchis J; Núñez J J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):681-689. PubMed ID: 38225218 [TBL] [Abstract][Full Text] [Related]
51. Right ventricular function and iron deficiency in acute heart failure. Miñana G; Santas E; de la Espriella R; Núñez E; Lorenzo M; Núñez G; Valero E; Bodí V; Chorro FJ; Sanchis J; Cohen-Solal A; Bayés-Genís A; Núñez J Eur Heart J Acute Cardiovasc Care; 2021 May; 10(4):406-414. PubMed ID: 33620455 [TBL] [Abstract][Full Text] [Related]
52. Prevalence and spectrum of iron deficiency in heart failure patients in south Rajasthan. Sharma SK; Agarwal SK; Bhargava K; Sharma M; Chopra K; Arumugam G Indian Heart J; 2016; 68(4):493-7. PubMed ID: 27543471 [TBL] [Abstract][Full Text] [Related]
53. Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. Ambrosy AP; Lewis GD; Malhotra R; Jones AD; Greene SJ; Fudim M; Coles A; Butler J; Sharma A; Hernandez AF; Mentz RJ J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):223-225. PubMed ID: 30540649 [TBL] [Abstract][Full Text] [Related]
54. Threshold Ferritin Concentrations Reflecting Early Iron Deficiency Based on Hepcidin and Soluble Transferrin Receptor Serum Levels in Patients with Absolute Iron Deficiency. Tarancon-Diez L; Genebat M; Roman-Enry M; Vázquez-Alejo E; Espinar-Buitrago MS; Leal M; Muñoz-Fernandez MÁ Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432426 [TBL] [Abstract][Full Text] [Related]
55. Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners. Drozd M; Jankowska EA; Banasiak W; Ponikowski P Am J Cardiovasc Drugs; 2017 Jun; 17(3):183-201. PubMed ID: 28039585 [TBL] [Abstract][Full Text] [Related]
56. Iron status determination in individuals with Helicobacter pylori infection: conventional vs. new laboratory biomarkers. Enko D; Wagner H; Kriegshäuser G; Wögerer J; Halwachs-Baumann G; Schnedl WJ; Zelzer S; Fauler G; Mangge H; Markus H; Meinitzer A Clin Chem Lab Med; 2019 Jun; 57(7):982-989. PubMed ID: 31154451 [TBL] [Abstract][Full Text] [Related]
57. Association between iron deficiency and hospitalization rate in community-dwelling older adults: A 3-year prospective observational study of DO-HEALTH. de Godoi Rezende Costa Molino C; Woll L; Wieczorek M; Abderhalden LA; Lanz P; Schaer DJ; Spahn DR; Orav EJ; Egli A; Bischoff-Ferrari HA; Am J Clin Nutr; 2023 Jan; 117(1):12-21. PubMed ID: 36789930 [TBL] [Abstract][Full Text] [Related]
58. Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study. Huth C; Beuerle S; Zierer A; Heier M; Herder C; Kaiser T; Koenig W; Kronenberg F; Oexle K; Rathmann W; Roden M; Schwab S; Seissler J; Stöckl D; Meisinger C; Peters A; Thorand B Eur J Endocrinol; 2015 Nov; 173(5):643-53. PubMed ID: 26294793 [TBL] [Abstract][Full Text] [Related]
59. Iron deficiency is highly prevalent among candidates for metabolic surgery and may affect perioperative outcomes. Benotti PN; Wood GC; Dove JT; Kaberi-Otarod J; Still CD; Gerhard GS; Bistrian BR Surg Obes Relat Dis; 2021 Oct; 17(10):1692-1699. PubMed ID: 34266778 [TBL] [Abstract][Full Text] [Related]
60. Iron deficiency and risk of early readmission following a hospitalization for acute heart failure. Núñez J; Comín-Colet J; Miñana G; Núñez E; Santas E; Mollar A; Valero E; García-Blas S; Cardells I; Bodí V; Chorro FJ; Sanchis J Eur J Heart Fail; 2016 Jul; 18(7):798-802. PubMed ID: 27030541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]